Coda Octopus appoints Gwenaël Rouy-Poirier to Board; Board expands to seven seats

Coda Octopus Group, Inc.

Board expands to seven seats; Gwenaël Rouy-Poirier elected director effective April 15, 2024.
Received inducement grant of 7,898 shares of common stock vesting on first anniversary of election.
Over 27 years experience, most recently interim CFO at SHL Medical in 2023, Group CFO at GKN Aerospace ($4B) until 2022.
Previously CFO roles at Honeywell, Nobel Biocare; holds Master of Management from EDHEC Business School.
Company notes his strong financial background and defense industry ties; products deployed at Baltimore Key Bridge.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Gwenaël Rouy-Poirier

Director

CODA · Coda Octopus Group, Inc.

Effective: 2024-04-15
Filed: April 15, 2024, 7:59 PM ET

On April 10, 2024, the Board of Directors (the “Board”) of Coda Octopus Group, Inc. (the “Company”) elected Gwenaël Rouy-Poirier as a director, effective April 15, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Gwenaël Rouy-Poirier was elected as Director at Coda Octopus Group, Inc..

Action: elected
Role: Director

Exact text from the filing

On April 10, 2024, the Board of Directors (the “Board”) of Coda Octopus Group, Inc. (the “Company”) elected Gwenaël Rouy-Poirier as a director, effective April 15, 2024.

View on SEC.gov

Coda Octopus Group, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-014673

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.